University Hospitals Harrington Heart & Vascular Institute
banner
harringtonhvi.bsky.social
University Hospitals Harrington Heart & Vascular Institute
@harringtonhvi.bsky.social
News from University Hospitals Harrington Heart & Vascular Institute in Cleveland, Ohio. Nationally recognized expertise and innovations @uhcleveland.bsky.social #cardiosky #vascsky
Don’t miss it! Hands-on training, live cases, debates and more at the Inaugural Cleveland Aortic Symposium: The Root, The Arch, The Works

View Agenda
cwru.cloud-cme.com/Assets/cwru/...

Register Online & Learn More
cwru.cloud-cme.com/course/cours...
August 13, 2025 at 5:08 PM
The Society of Thoracic Surgeons has awarded @harringtonhvi.bsky.social a 3-star rating, its highest designation, for CABG quality outcomes. Only 20% of hospitals nationally have a 3-star rating. @uhcleveland.bsky.social @sts.org #cardiosky
news.uhhospitals.org/news-release...
UH Receives Highest Designation for Quality Outcomes for Coronary Artery Bypass Grafting
3-star recognition from the Society of Thoracic Surgeons.
news.uhhospitals.org
July 7, 2025 at 4:10 PM
Reposted by University Hospitals Harrington Heart & Vascular Institute
Excited to share that my colleagues, Drs Robert Goldstein and Samer de Oliveira, at UH Lake West Hospital are performing Pulsed Field Ablation to treat Afib! @harringtonhvi.bsky.social
@nejm.org nejm.org/doi/full/10.1056/NEJMoa2502280
June 3, 2025 at 1:26 PM
First in Ohio to clinically administer FDA-approved PET MPI agent Flyrcado (flurpiridaz F 18) injection in patients with known or suspected CAD. “One of the most groundbreaking advancements in nuclear cardiology in decades.” #cardiosky

news.uhhospitals.org/news-release...
UH First Site in Ohio to Provide More Accurate and Convenient PET MPI Cardiac Stress Test
First-of-its-kind F 18 radiopharmaceutical helps physicians better detect blockages in heart arteries that can lead to heart attacks.
news.uhhospitals.org
July 1, 2025 at 12:25 PM
"An important advancement in PE care.” – Dr. Jun Li, Co-Director, Vascular Center @harringtonhvi.bsky.social and national co-PI of Inquis Medical’s AVENTUS thrombectomy system shared trial results at @scainews.bsky.social Scientific Sessions @uhreinstitute.bsky.social www.jscai.org/article/S277...
Novel Aspiration Thrombectomy and Blood Reinfusion System for Acute Intermediate-Risk Pulmonary Embolism: AVENTUS Trial Results
Mechanical thrombectomy has become a first-line adjunctive therapy for anticoagulation in patients with acute intermediate-risk pulmonary embolism (PE). This prospective study evaluated the safety and...
www.jscai.org
May 8, 2025 at 12:26 PM
Reposted by University Hospitals Harrington Heart & Vascular Institute
Congratulations Dr Varun Sundaram! Transform-AF presented as a LBCT- demonstrated impact of SGLP-1 on reducing AF with just modest weight loss. A potential gamechanger! TOP 3 #HRS2025 Pacesetter Pick. Saksena commentary “transformative”. @harringtonhvi.bsky.social @heartrhythmsociety.bsky.social
April 28, 2025 at 1:09 PM
Reposted by University Hospitals Harrington Heart & Vascular Institute
UH Harrington HVI Reunion @HeartRhythm2025
What a night! Alumni/Faculty/Fellows spanning 40 years of EP at UH!!! RIP ALW
April 28, 2025 at 12:42 PM
Extravascular ICDs can address limitations of transvenous ICDs, providing effective defibrillation with improved pacing capabilities. Two investigational exemption trials helped bring novel options to market. @judymackall.bsky.social #cardiosky

www.uhhospitals.org/for-clinicia...
Trials at University Hospitals Harrington Heart & Vascular Institute Advance Leadless Pacemakers and Extravascular ICDs | Cleveland, Ohio
Innovations in Cardiovascular Medicine & Surgery | March 2025
www.uhhospitals.org
April 28, 2025 at 12:20 PM